4//SEC Filing
INTERMOLECULAR INC 4
Accession 0001311241-13-000168
CIK 0001311241operating
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:45 PM ET
Size
9.0 KB
Accession
0001311241-13-000168
Insider Transaction Report
Form 4
Eidelman Peter L.
Chief Financial Officer
Transactions
- Sale
Common Stock, $0.001 par value
2013-06-17$7.30/sh−6,500$47,449→ 28,535 total - Exercise/Conversion
Common Stock, $0.001 par value
2013-06-17$0.20/sh+6,500$1,300→ 35,035 total - Exercise/Conversion
Stock Option (right to buy)
2013-06-17−6,500→ 234,500 totalExercise: $0.20Exp: 2016-05-04→ Common Stock (6,500 underlying)
Footnotes (3)
- [F1]The sale reported was effected pursuant to a Rule 10b5-1 Sales Plan adopted by Mr. Eidelman on May 11, 2012.
- [F2]The transaction was executed in multiple trades in prices ranging from $7.065 to $7.39, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F3]The option was immediately exercisable in full on May 5, 2006; however, the shares vested pursuant to the following schedule: Twenty-Five Percent (25%) of the shares subject to the original option (312,500) vested on the first anniversary measured from February 27, 2006 (the "Vesting Commencement Date") and the remaining shares subject to the option vested in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date.
Documents
Issuer
INTERMOLECULAR INC
CIK 0001311241
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001311241
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:45 PM ET
- Size
- 9.0 KB